Skip to main content

Summit Global Investments

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1697953 BOUNTIFUL, UT

Position in TAK

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$2,157,468
+$530,293 QoQ
Shares Held
116,494
+11.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
18 quarters on record

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Summit Global Investments holds $9,305,086 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (23.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TAK
Takeda Pharmaceutical Co Ltd
This page
116,494 $2,157,468

All Filings in TAK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,157,468 116,494
2025-12-31 $1,627,175 104,373
2025-09-30 $1,247,357 85,202
2025-06-30 $2,808,355 181,653
2025-03-31 $5,215,488 350,739
2024-12-31 $9,654,608 729,200
2024-09-30 $5,909,234 415,558
2024-06-30 $2,890,990 223,415
2024-03-31 $3,580,744 257,793
2023-12-31 $4,829,182 338,415
2023-09-30 $5,202,932 336,324
2023-06-30 $1,405,070 89,438
2021-09-30 $2,084,142 127,237
2021-06-30 $2,024,817 120,310
2021-03-31 $2,363,300 129,425
2020-12-31 $3,676,436 202,002
2020-09-30 $2,146,544 120,322
2020-06-30 $1,406,357 78,436